Politics Oct 10 WATCH: Trump announces deal with AstraZeneca to lower drug prices for Medicaid By Will Weissert, Associated Press
Politics Sep 30 WATCH: Trump announces Pfizer deal to lower drug prices Under the agreement, New York-based Pfizer will charge most-favored-nation pricing to Medicaid and guarantee that pricing on newly launched drugs, President Donald Trump said. That involves matching the lowest price offered in other developed nations. By Tom Murphy, Michelle L. Price, Associated Press
Nation May 12 Watch 6:33 What to expect after Trump signs order demanding lower prices from drug companies In the U.S., pharmaceutical companies set the prices of drugs with few restraints. In many cases, Americans pay a lot more compared to Canadians or Europeans. President Trump signed an executive order directing that Americans will pay the lowest price… By Stephanie Sy, Jackson Hudgins
Politics May 12 WATCH: Trump says he’ll set 30-day deadline for drugmakers to lower prescription drug prices If a deal is not reached, a new rule will kick in that will tie the price of what the U.S. pays for medications to lower prices paid by other countries. By Will Weissert, Amanda Seitz, Seung Min Kim, Associated Press
Health Apr 14 Pfizer abandons potential obesity treatment pill The drugmaker said Tuesday that it would stop studying danuglipron after a participant in one of its trials experienced a possible drug-induced liver injury that ended once the person stopped taking the treatment. By Tom Murphy, Associated Press
Oct 30 Watch 8:59 How the prolonged ADHD medication shortage is straining patients and their families By Stephanie Sy, Diane Lincoln Estes Since the pandemic eased, millions of Americans have had to deal with several drug shortages. For those with ADHD, it's been an especially difficult year as they and their families have struggled to get through ordinary daily routines. Stephanie Sy… Continue watching
Mar 05 Analysis: Eli Lilly is capping insulin copays at $35. Here are 5 questions answered By Dana Goldman, Karen Van Nuys, The Conversation Two scholars who have researched insulin pricing explain why Eli Lilly is dramatically cutting the cost of some of its insulin products and how it may improve access to this essential medical treatment. Continue reading
Sep 25 COVID-19 vaccine boosters could mean billions for drugmakers By Tom Murphy, Associated Press Billions more in profits are at stake for some vaccine makers as the U.S. moves toward dispensing COVID-19 booster shots to shore up Americans’ protection against the virus. Continue reading
Jul 20 U.S. opioid lawsuits on verge of settlements with 4 companies By Geoff Mulvihill, Associated Press Full details of the settlement involving AmerisourceBergen, Cardinal Health and McKesson could come this week but it could take months to get final approval from state and local governments. Continue reading
Dec 08 U.S. is taking final steps to review the first COVID-19 vaccine. Here’s what’s next By Associated Press The Food and Drug Administration posted a positive review of the Pfizer vaccine on Tuesday and will hold a public hearing on Thursday. The Associated Press has a look at the process. Continue reading